Luma, a Life-Sciences Investor, Debuts a $410 Million Fund — WSJ
By Brian GormleyInvestments in biomedical startups can take more than a decade to pay off. The structure of the new $410 million venture fund from life-sciences investor Luma Group reflects that and a bit more.The fundMost venture-capital funds are 10-year limited partnerships, so investors expect…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.